secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001558370-25-006531
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn appoints Robert E. Hoffman as CFO effective May 15, 2025
----------------------------------------------------------------

- Hoffman replaces interim CFO Mitch Cohen; Cohen resigns effective May 12 with last day May 30.
- Compensation includes $450,000 base salary, 40% target bonus, option for 1M shares, PSUs for 3.5M shares.
- Hoffman has 30+ years biotech experience; previously CFO at Heron Therapeutics, AnaptysBio, and Arena Pharmaceuticals.
- Hoffman currently serves on boards of Esperion Therapeutics, TuHURA Biosciences, and Fibrobiologics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837025006531/0001558370-25-006531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837025006531/cydy-20250502x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-006531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer